Description
LY-3177833 is an inhibitor of Cdc7, a therapeutic target for some cancers. It slows tumor growth in human colorectal adenocarcinoma cell lines in vitro.
| Product Unit Size | Cost | Quantity | Stock |
|---|
LY-3177833 is an inhibitor of Cdc7, a therapeutic target for some cancers. It slows tumor growth in human colorectal adenocarcinoma cell lines in vitro.
| Cas No. | 1627696-51-8 |
|---|---|
| Purity | ≥99% |
| Formula | C16H12FN5O |
| Formula Wt. | 309.30 |
| Chemical Name | LY-3177833 |
| IUPAC Name | (3R)-3-(5-Fluoro-4-pyrimidinyl)-3-methyl-6-(1H-pyrazol-4-yl)-1-isoindolinone |
| Synonym | LY 3177833, LY3177833 |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet |
Cheng A., Lo Y., et al. Identification of Novel Cdc7 Kinase Inhibitors as Anti-Cancer Agents that Target the Interaction with Dbf4 by the Fragment Complementation and Drug Repositioning Approach. EBioMedicine. 36:241-251 (2018). PMID: 30293817.
Cell-membrane permeable heterocyclic light-emit...
CDK4/6 inhibitor.
Aminothiol, CoA component; ulcer inducer.
Cysteine-ITC conjugate, antioxidant; aldehyde d...
Peptide; galanin antagonist.
Synthesis impurity
Anthraquinone found in various plant sources.
Taxane synthesis intermediate.
EGFR inhibitor.
SK K+ channel blocker, EGFR inhibitor.
Peptide fragment of HER2/neu/erbB2 receptor.
VEGFR1/2/3, TIE2, PDGFRβ, FGFR1, c-Kit, RET, B...
Pyrimidine derivative; kinesin Eg5 inhibitor.
ACE inhibitor.
Amino acid alcohol.
Fluoroquinolone; topoisomerase IV and bacterial...
CB1 inverse agonist.
σ1 antagonist.
Triterpene saponin found in species of Panax; P...
Selective 5-HT6 receptor antagonist